nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-2ED5FB96·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Clinical medicine·Subfield: Epidemiology·Basis: Full text·Type: Cross-sectional study

Cognitive, biomarker, and neuroimaging indices associated with traumatic encephalopathy syndrome across two independent athlete cohorts.

Conway Kleven et al.Conway Kleven, Chien, Surwill et al.·2026·Alzheimer's research & therapy·10.1186/s13195-026-02110-8 ↗

Primary claim

TES in RHI-exposed athletes was associated with a convergent clinicobiological profile across two independent cohorts.

Tentative · cohort-specific biological patterns and cognitive-outcome overlap weaken the claimed convergence
In brief

A useful two-cohort multimodal analysis links biological indices to TES, but cognitive-outcome overlap and in-sample performance limit diagnostic interpretation.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

BACKGROUND: Traumatic encephalopathy syndrome (TES) is a clinical research construct used to identify individuals at risk for chronic traumatic encephalopathy (CTE) following exposure to repetitive head impacts (RHI). Adjudication of TES relies on clinical features such as progressive cognitive impairment and neurobehavioral dysregulation. Blood-based biomarkers and structural neuroimaging abnormalities have been associated with TES but are not part of the criteria. This study evaluated whether TES identification was associated with the combined contribution of cognitive performance, blood biomarkers, and structural neuroimaging measures across two well-characterized cohorts.

METHODS: Participants included 158 professional fighters from the Professional Athletes Brain Health Study and 149 former American football players from The DIAGNOSE CTE Research Project. Three indices were constructed representing complementary domains: a cognitive index reflecting cohort-specific cognitive features, a blood biomarker index including plasma neurofilament light chain, glial fibrillary acidic protein, total tau, tau phosphorylated at amino acid 231, and APOE-ε4 carrier status, and an imaging index comprising volumetric MRI measures of subcortical structures, ventricles, and corpus callosum subregions. Grouped weighted quantile sum regression models were estimated within each cohort to evaluate associations between these indices and TES while adjusting for age, race, competition status, and RHI exposure.

RESULTS: Multidomain models demonstrated improved model performance compared with single-domain models in both cohorts (PABHS: AUC = 0.91, PPV = 0.80; DIAGNOSE CTE: AUC = 0.84, PPV = 0.85). Biomarker and imaging indices contributed additional information across cohorts, although imaging contributions were more prominent in fighters whereas blood biomarker associations were stronger in football players.

CONCLUSION: TES in RHI-exposed athletes was associated with a convergent clinicobiological profile observed across two independent cohorts with distinct exposure patterns. These findings support multidomain analytic frameworks for evaluating correlated biological signals in RHI-exposed populations and may inform future studies of TES and CTE.

Key Claims

Primary finding · Tentative

TES in RHI-exposed athletes was associated with a convergent clinicobiological profile across two independent cohorts.

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

cohort-specific biological patterns and cognitive-outcome overlap weaken the claimed convergence

Conclusion
Quote verified
Secondary · Supported

Multidomain models demonstrated improved model performance compared with single-domain models in both cohorts.

reported AUCs increase within both cohorts, but all comparisons are in-sample and untested formally

Abstract, Results; Conclusion
Quote verified
Secondary · Supported

Biomarker and imaging indices remained associated with TES when the cognitive index was excluded from the model.

adjusted biological-only models support both domains, though biomarker estimates are borderline and cohort-specific

Results, Sensitivity Analysis; Table 3
Secondary · Supported

Biomarker and imaging indices contributed additional information across cohorts, although imaging contributions were more prominent in fighters while biomarker associations were stronger in football players.

cohort-specific primary models and sensitivity analyses support differing domain contributions with limited cross-cohort uniformity

Abstract, Results; Conclusion
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Two distinct athlete cohorts analyzed

Separate analyses of professional fighters and former football players test the multimodal framework across different RHI exposure patterns rather than relying on one sport-specific sample.

↳ Methods, Study Population; Results, Table 1

#methodological rigour

Sensitivity analysis addresses outcome overlap

Because cognition contributes to TES adjudication, the study repeats the models using only biomarker and imaging indices. This directly tests whether biological associations persist without the overlapping cognitive index.

↳ Methods, Cognitive Index; Results, Sensitivity Analysis; Table 3

#positioning

Important limitations are explicitly traced

The Discussion identifies absent pathological confirmation, limits on causal inference, normative mismatch, and the lack of validated individual classification, then describes the findings as descriptive and hypothesis-generating.

↳ Discussion, limitations paragraphs

Limitations

#methodological rigour

Cognitive predictor overlaps TES classification

The strongest predictor contains cognitive measures that partly contribute to TES adjudication, so the headline AUCs are not independent diagnostic-validation estimates.

↳ Methods, Cognitive Index and TES Adjudication; Table 2

#methodological rigour

Performance remains entirely in-sample

AUC, PPV, sensitivity, and specificity are reported at a Youden-optimal threshold without external validation or a formal comparison of AUC gains. This limits claims of improved performance and near-term translation.

↳ Methods, Data Analysis; Results, Table 2

#reporting

Narrative and tables do not align

The PABHS Results misattribute uni-index odds ratios to the unadjusted multi-index model and describe the uni-index biomarker result as nonsignificant despite Table 2 reporting p=0.0045.

↳ Results, PABHS subsection; Table 2

Does this match your read? Add your assessment ↓

Nabu Commentary

The two-cohort design and biological-only sensitivity analysis make the study a useful multimodal contribution to TES research. Methodological confidence is limited because cognition partly defines the outcome, participants with critical missing data are not characterized, and performance is assessed only within the analyzed samples. Tables 2 and 3 support biological associations, but the significant domains differ in the primary cohort models and some sensitivity estimates are borderline. The Discussion appropriately limits causal and diagnostic interpretation, although its stratification claims remain premature.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.2±0.2

Contribution
3.4

The study adds a two-cohort multimodal GWQS analysis to a literature commonly organized around individual markers. The advance remains incremental because the indices are cohort-specific and the analysis addresses TES rather than pathologically confirmed CTE.

Introduction, final paragraph; Methods, Data Analysis; Conclusion

multidomain models integrating cognitive, biomarker, and neuroimaging indices demonstrated stronger discrimination of TES than single-domain models

Methodological Rigour
2.8

Prespecified imaging regions, a priori biomarkers, covariate adjustment, Firth correction, calibration, and a biological-only sensitivity analysis support the design. Cognitive-outcome overlap, uncharacterized missing-data exclusions, and in-sample performance estimates introduce material uncertainty.

Methods, Study Population, Cognitive Index, and Data Analysis; Tables 2–3

the cognitive index is not independent of the outcome

Reporting
3.5

The article follows a coherent progression from cohort-specific methods to primary and sensitivity analyses and generally uses associative language. Precision is reduced by text-table discrepancies and by describing cohort-specific biological patterns as convergent.

Abstract; Results, PABHS subsection; Table 2; Conclusion

a convergent clinicobiological profile across two independent cohorts

Positioning
3.7

The Discussion addresses pathological confirmation, causal limits, age differences, normative mismatch, and the lack of individual diagnostic validation. Its proposed stratification use is nevertheless stronger than warranted by the in-sample, cohort-level analyses.

Discussion, limitations and translational paragraphs

should not be interpreted as validated diagnostic algorithms for individual patient classification

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Biomarker and imaging indices contributed additional information across cohorts, although imaging contributions were more prominent in fighters while biomarker associations were stronger in football players: "In the unadjusted multi-index model, higher values (improved scores) of the cognitive index were associated with 75% decreased odds of TES (OR = 0.25; 95% confidence interval [CI] = 0.16, 0.37; p-value<0.0001) and higher values of the imaging index were associated with 70% lower odds of TES (OR = 0.30; 95% CI = 0.20, 0.43; p-value<0.0001)." (Results, PABHS, first paragraph) vs "Unadjusted Multi-Index Model0.870.70  Cognitive index0.330.210.50< 0.0001  Blood Biomarker index0.950.501.790.8610  Imaging index0.450.280.720.0009" (Table 2, PABHS unadjusted multi-index model). Comparing the narrative with Table 2 replaces cognitive OR 0.25 with 0.33 and imaging OR 0.30 with 0.45, corresponding to 67% and 55% lower odds rather than 75% and 70%, while both associations remain significant. → Conclusion holds
  • Multidomain models demonstrated improved model performance compared with single-domain models in both cohorts: "The adjusted multi-index model including age, race, competition status (college vs. professional), and RHI exposure (years of football) as covariates indicated the best fit for this dataset (AUC = 0.84; PPV = 0.84)." (Results, DIAGNOSE CTE, second paragraph) vs "Multidomain models demonstrated improved model performance compared with single-domain models in both cohorts (PABHS: AUC = 0.91, PPV = 0.80; DIAGNOSE CTE: AUC = 0.84, PPV = 0.85)." (Abstract, Results). The DIAGNOSE CTE adjusted-model PPV is 0.84 in the Results narrative but 0.85 in the Abstract and Table 2; using 0.85 leaves the reported AUC and overall model-performance pattern unchanged. → Conclusion holds
Reporting and transparencyNoted

The generic cognitive-index threshold omits the distinct PABHS threshold, although the Results apply it correctly. Written informed consent is reported, but explicit ethics committee or IRB approval is not stated in the supplied article.

Ethics approval: not stated

Reference IntegrityClean

38 references in manuscript 38 of 38 checkable references found in an index

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Neurological · Other neurological disorders
Type of advanceEmpirical
Route to useSpecified
AdvanceExtends
BeneficiariesCatch-all cause
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessValidated
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary association was reproduced in two separately recruited, demographically distinct athlete cohorts, one with multi-site imaging, confirming it beyond a single sample.

From the paper
“the multi-index model developed here can serve as a stratification tool for identifying high-risk individuals or as an inclusion criterion for clinical trials”

The paper names the setting and decision explicitly: clinical trials would apply the multi-index model as a stratification tool and inclusion criterion for identifying high-risk individuals.

Pathway

CTE researchers and clinical trial teams would use the combined cognitive, blood biomarker, and MRI indices to stratify RHI-exposed athletes and select participants for therapeutic trials.

Barrier

Without post-mortem pathological confirmation the indices cannot yet be tied to CTE itself, and the models lack external validation and clinically meaningful thresholds for individual use.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21

    2026 · Health sciences

    Primary claim

    At minimum, nearly a quarter of all former NFL players who died during 2016-21 had CTE neuropathology at death.

    Well-supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats
  2. Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal Summit

    Bernick, Kleven, Alosco, et al. · 2026 · Basic medicine

    Primary claim

    There is no validated fluid biomarker for CTE.

    Supported
    Evidence Score
    3.4±0.2
    Reliability
    No concerns
  3. Traumatic brain injury and risk of early-onset dementia: A population-based cohort study

    Saravanan, Giorgio, Lakomski, et al. · 2026 · Clinical medicine

    Primary claim

    TBI was associated with higher risk of both EOD (HR: 4.06 [95% confidence interval: 3.13, 5.26]) and LOD (HR: 2.51 [2.31, 2.72]

    Supported
    Evidence Score
    3.5±0.2
    Reliability
    Caveats

How the rubric works →